Copyright Reports & Markets. All rights reserved.

Global Alpha Blockers Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Alpha Blockers Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Alpha Blockers Market Size Growth Rate by Product
      • 1.4.2 Non-selective Antagonists
      • 1.4.3 Selective Antagonists
    • 1.5 Market by End User
      • 1.5.1 Global Alpha Blockers Market Size Growth Rate by End User
      • 1.5.2 Hypertension
      • 1.5.3 Raynaud's Disease
      • 1.5.4 Erectile Dysfunction
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Alpha Blockers Market Size
      • 2.1.1 Global Alpha Blockers Revenue 2014-2025
      • 2.1.2 Global Alpha Blockers Sales 2014-2025
    • 2.2 Alpha Blockers Growth Rate by Regions
      • 2.2.1 Global Alpha Blockers Sales by Regions
      • 2.2.2 Global Alpha Blockers Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Alpha Blockers Sales by Manufacturers
      • 3.1.1 Alpha Blockers Sales by Manufacturers
      • 3.1.2 Alpha Blockers Sales Market Share by Manufacturers
      • 3.1.3 Global Alpha Blockers Market Concentration Ratio (CR5 and HHI)
    • 3.2 Alpha Blockers Revenue by Manufacturers
      • 3.2.1 Alpha Blockers Revenue by Manufacturers (2014-2019)
      • 3.2.2 Alpha Blockers Revenue Share by Manufacturers (2014-2019)
    • 3.3 Alpha Blockers Price by Manufacturers
    • 3.4 Alpha Blockers Manufacturing Base Distribution, Product Types
      • 3.4.1 Alpha Blockers Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Alpha Blockers Product Type
      • 3.4.3 Date of International Manufacturers Enter into Alpha Blockers Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Alpha Blockers Sales by Product
    • 4.2 Global Alpha Blockers Revenue by Product
    • 4.3 Alpha Blockers Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Alpha Blockers Breakdown Data by End User

    6 North America

    • 6.1 North America Alpha Blockers by Countries
      • 6.1.1 North America Alpha Blockers Sales by Countries
      • 6.1.2 North America Alpha Blockers Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Alpha Blockers by Product
    • 6.3 North America Alpha Blockers by End User

    7 Europe

    • 7.1 Europe Alpha Blockers by Countries
      • 7.1.1 Europe Alpha Blockers Sales by Countries
      • 7.1.2 Europe Alpha Blockers Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Alpha Blockers by Product
    • 7.3 Europe Alpha Blockers by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Alpha Blockers by Countries
      • 8.1.1 Asia Pacific Alpha Blockers Sales by Countries
      • 8.1.2 Asia Pacific Alpha Blockers Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Alpha Blockers by Product
    • 8.3 Asia Pacific Alpha Blockers by End User

    9 Central & South America

    • 9.1 Central & South America Alpha Blockers by Countries
      • 9.1.1 Central & South America Alpha Blockers Sales by Countries
      • 9.1.2 Central & South America Alpha Blockers Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Alpha Blockers by Product
    • 9.3 Central & South America Alpha Blockers by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Alpha Blockers by Countries
      • 10.1.1 Middle East and Africa Alpha Blockers Sales by Countries
      • 10.1.2 Middle East and Africa Alpha Blockers Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Alpha Blockers by Product
    • 10.3 Middle East and Africa Alpha Blockers by End User

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer Alpha Blockers Products Offered
      • 11.1.5 Pfizer Recent Development
    • 11.2 Novartis
      • 11.2.1 Novartis Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Novartis Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Novartis Alpha Blockers Products Offered
      • 11.2.5 Novartis Recent Development
    • 11.3 Merck
      • 11.3.1 Merck Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merck Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merck Alpha Blockers Products Offered
      • 11.3.5 Merck Recent Development
    • 11.4 Astra Zeneca
      • 11.4.1 Astra Zeneca Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Astra Zeneca Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Astra Zeneca Alpha Blockers Products Offered
      • 11.4.5 Astra Zeneca Recent Development
    • 11.5 Jhonson and Johnson
      • 11.5.1 Jhonson and Johnson Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Jhonson and Johnson Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Jhonson and Johnson Alpha Blockers Products Offered
      • 11.5.5 Jhonson and Johnson Recent Development
    • 11.6 Eli Lilly
      • 11.6.1 Eli Lilly Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Eli Lilly Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Eli Lilly Alpha Blockers Products Offered
      • 11.6.5 Eli Lilly Recent Development
    • 11.7 Sanofi
      • 11.7.1 Sanofi Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Sanofi Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Sanofi Alpha Blockers Products Offered
      • 11.7.5 Sanofi Recent Development
    • 11.8 Bristol-Myers Squibb
      • 11.8.1 Bristol-Myers Squibb Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Bristol-Myers Squibb Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Bristol-Myers Squibb Alpha Blockers Products Offered
      • 11.8.5 Bristol-Myers Squibb Recent Development
    • 11.9 Bayer
      • 11.9.1 Bayer Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Bayer Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Bayer Alpha Blockers Products Offered
      • 11.9.5 Bayer Recent Development
    • 11.10 GSK
      • 11.10.1 GSK Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 GSK Alpha Blockers Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 GSK Alpha Blockers Products Offered
      • 11.10.5 GSK Recent Development
    • 11.11 Teva Pharmaceutical

    12 Future Forecast

    • 12.1 Alpha Blockers Market Forecast by Regions
      • 12.1.1 Global Alpha Blockers Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Alpha Blockers Revenue Forecast by Regions 2019-2025
    • 12.2 Alpha Blockers Market Forecast by Product
      • 12.2.1 Global Alpha Blockers Sales Forecast by Product 2019-2025
      • 12.2.2 Global Alpha Blockers Revenue Forecast by Product 2019-2025
    • 12.3 Alpha Blockers Market Forecast by End User
    • 12.4 North America Alpha Blockers Forecast
    • 12.5 Europe Alpha Blockers Forecast
    • 12.6 Asia Pacific Alpha Blockers Forecast
    • 12.7 Central & South America Alpha Blockers Forecast
    • 12.8 Middle East and Africa Alpha Blockers Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Alpha Blockers Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Alpha-blockers, also known as α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
      The global Alpha Blockers market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alpha Blockers market based on company, product type, end user and key regions.

      This report studies the global market size of Alpha Blockers in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alpha Blockers in these regions.
      This research report categorizes the global Alpha Blockers market by top players/brands, region, type and end user. This report also studies the global Alpha Blockers market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Pfizer
      Novartis
      Merck
      Astra Zeneca
      Jhonson and Johnson
      Eli Lilly
      Sanofi
      Bristol-Myers Squibb
      Bayer
      GSK
      Teva Pharmaceutical

      Market size by Product
      Non-selective Antagonists
      Selective Antagonists
      Market size by End User
      Hypertension
      Raynaud's Disease
      Erectile Dysfunction

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Alpha Blockers market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Alpha Blockers market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Alpha Blockers companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Alpha Blockers submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Alpha Blockers are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alpha Blockers market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now